Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Native-joint septic arthritis

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
A septic native joint can destroy cartilage and seed sepsis rapidly

Bacterial replication in synovial fluid drives intense inflammation, pressure and cartilage injury; fever may be absent and crystals or a modest synovial white-cell count do not safely exclude simultaneous infection.

Action: Assess ABCDE and all possible infection sources, obtain blood cultures and urgent sterile joint aspiration, start intravenous antibiotics immediately after sampling or before aspiration if sepsis makes delay unsafe, and arrange prompt orthopaedic washout for a large peripheral joint or any joint with pus, deterioration or inadequate response.

Synopsis

Approach an acutely inflamed native joint as a time-dependent diagnostic and source-control problem, aspirate before antibiotics when physiology permits, interpret synovial findings safely, and coordinate drainage and targeted therapy.

  • Any acutely hot, swollen and movement-limited native joint warrants septic-arthritis assessment; absence of fever or normal serum markers cannot safely exclude it.
  • Aspirate synovial fluid as quickly as practical for cell count and differential, Gram stain, aerobic and anaerobic culture and crystals; inoculation into blood-culture bottles may improve yield under laboratory protocol.
  • Take at least two sets of blood cultures in febrile or bacteraemic presentations and investigate the skin, urine, lungs, heart, injection sites and other joints for source and spread.
  • In a stable patient, collect synovial and blood specimens before antibiotics. In sepsis or shock, obtain rapidly available blood cultures and give intravenous antibiotics without waiting for aspiration.
  • Synovial white-cell count increases probability but no universal cutoff excludes infection; immunosuppression and early disease can produce lower counts, and crystals do not rule out bacteria.
  • Plain radiographs establish baseline and alternatives; ultrasound detects and guides aspiration of effusion, while MRI answers deep-joint, osteomyelitis or abscess questions.
  • Prompt surgical debridement is generally recommended for a septic large native joint; serial aspiration is an exception selected by senior teams for specific accessible presentations.
  • Narrow treatment to cultures, drain again when clinical or CRP response fails, mobilise after infection control and search for endocarditis or metastatic foci when bacteraemia persists.

Key red flags

Hypotension, confusion, lactate elevation, rigors or rapidly progressive illness requires sepsis treatment and antibiotics after blood cultures without waiting for image-guided aspiration.

A hot painful prosthetic joint follows a separate implant-infection pathway; this route applies to native cartilage and must not be used to justify simple aspiration of a prosthesis.

Hip, shoulder, sternoclavicular, sacroiliac or spinal-region symptoms can hide a deep septic focus and require urgent specialist imaging and drainage planning.

Bacteraemia, a new murmur, embolic lesions, multiple painful joints or S. aureus in blood cultures raises concern for endocarditis and metastatic infection.

Investigation priorities

01
Urgent synovial aspirationFirst step

Obtain direct joint microbiology before antibiotics when safe.

Management branches

SepticCulture rapidly and treat immediately

Organ dysfunction or high-risk sepsis accompanies a suspected infected native joint.

  1. Start ABCDE sepsis care and call orthopaedics, anaesthesia, microbiology and the relevant medical team.
  2. Take rapidly obtainable blood cultures, then give local empirical intravenous therapy without waiting for image-guided aspiration.
  3. Aspirate and drain the joint at the earliest safe opportunity and collect synovial tissue for culture.
  4. Track blood-culture clearance and investigate endocarditis, osteomyelitis and other metastatic foci.
StableAspirate before antibiotics

A native-joint effusion and movement pain are present without physiological instability.

  1. Obtain blood tests, blood cultures when indicated and urgent sterile synovial fluid before antimicrobial exposure.
  2. Send differential count, Gram stain, aerobic and anaerobic culture and crystals, preserving volume for microbiology.
  3. Start protocol intravenous treatment immediately after sampling and arrange prompt operative drainage for a septic large joint.
  4. Tailor drugs and the need for repeat washout from cultures, anatomy and clinical and CRP trajectory.

Key medicines

Empirical intravenous native-joint therapyImmediately after synovial and indicated blood cultures in a stable adult, give the full dose and interval in the trust's native-joint septic-arthritis protocol; if sepsis is present, give it after rapidly obtainable blood cultures even when aspiration has not yet occurred.Choice changes with allergy, renal function, MRSA risk, Gram stain, injecting exposure, sexual history and prior isolates; specify the exact agent and review point, then narrow promptly rather than continuing broad coverage by default.
Ceftriaxone for confirmed or strongly suspected disseminated gonococcal infectionUse ceftriaxone 1 g intramuscularly or intravenously every 24 hours under sexual-health and microbiology direction for disseminated gonococcal infection, then adapt duration and any oral step-down to cultures, susceptibilities and clinical response.Obtain joint and genital or extragenital cultures where possible for resistance, assess immediate cephalosporin allergy, pregnancy and coinfections, and complete partner notification and test-of-cure arrangements through sexual-health services.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Guideline for management of septic arthritis in native joints
  • BOASt - The Management of Children with Acute Musculoskeletal Infection
  • NICE NG253 - Managing suspected sepsis
  • BASHH national guideline for gonorrhoea

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom